Abstract
Background
Weight loss in morbidly obese patients is associated with changes in thyroid function. Studies have demonstrated equivalent changes following bariatric surgery. Changes in thyroid function were reported following laparoscopic Roux-en-Y gastric bypass (LRYGB), biliopancreatic diversion (BPD), and laparoscopic adjustable gastric banding (LAGB). No data exists on changes in thyroid function following laparoscopic sleeve gastrectomy (LSG). The aim of the current study is to evaluate changes in thyroid function following LSG in patients with normal thyroid function.
Methods
Data were retrieved from a prospectively collected database of patients who underwent LSG for morbid obesity. Euthyroid patients were evaluated for changes in TSH and free thyroxine (FT4), 6–12 months after surgery. Correlation between changes in thyroid hormone levels, excess weight loss (EWL), and baseline TSH were evaluated.
Results
Thirty-eight patients were included in the study. Mean BMI decreased from 42.4 to 32.5 kg/m2 (P < 0.0001). Mean TSH levels decreased from 2.45 ± 0.17 mU/L at baseline to 1.82 ± 0.18 mU/L (P < 0.0001), whereas mean FT4 levels remained the same after surgery (13.27 ± 0.45 pmol/L compared to 12.96 ± 0.42 pmol/L, P = NS). TSH decrease was directly related to baseline TSH but did not correlate with EWL.
Conclusions
This is the first study to evaluate changes in thyroid hormone levels following LSG for morbid obesity. TSH decrease and steady levels of FT4 are expected following LSG. These findings are comparable to reported changes following LRYGB. TSH decrease was not associated with EWL. Further studies are required to elucidate the exact mechanism of this effect.
Similar content being viewed by others
References
Michalaki MA, Vagenakis AG, Leonardou AS, et al. Thyroid function in humans with morbid obesity. Thyroid. 2006;16, no. 1:73–8.
Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes (Lond). 2006;30, no. 1:100–5.
Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90, no. 7:4019–24.
Solanki A, Bansal S, Jindal S, et al. Relationship of serum thyroid stimulating hormone with body mass index in healthy adults. Indian J Endocrinol Metab. 2013;17, no. Suppl 1:S167–169.
Agnihothri RV, Courville AB, Linderman JD, et al. Moderate weight loss is sufficient to affect thyroid hormone homeostasis and inhibit its peripheral conversion. Thyroid. 2014;24(1):19–26.
Schäffler A, Binart N, Schölmerich J, et al. Hypothesis paper. Brain talks with fat—evidence for a hypothalamic-pituitary-adipose axis? Neuropeptides. 2005;9, no. 4:363–7.
Pontikides N, Krassas GE. Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid. 2007;17, no. 5:421–31.
Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;82, no. 6588:250–2.
M. Rosenbaum, M. Nicolson, J. Hirsch, et al. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab. 1997;82(11):3647–54.
Kozlowska L, Rosolowska-huszcz D. Thyrotropin and leptin hormones in obese/overweight women before and after. Thyroid. 2004;24, no. 2:147–53.
M. Rosenbaum, E. M. Murphy, S. B. Heymsfield, et al. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. Endocrine Society, 02-Jul-2013.
Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310, no. 22:2416–25.
Moulin de Moraes CM, Mancini MC, de Melo ME, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg. 2005;15, no. 9:1287–91.
Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 2007;3, no. 6:631–5. discussion 635–6.
MacCuish A, Razvi S, Syed AA. Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity. Clin Obes. 2012;2(1–2):25–8.
Dall’Asta C, Paganelli M, Morabito A, et al. Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function. Obesity (Silver Spring). 2010;18, no. 4:854–7.
Rosenthal RJ, Diaz AA, Arvidsson D, et al. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis. 2012;8(1):8–19.
Fazylov R, Soto E, Cohen S, et al. Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism. Obes Surg. 2008;8, no. 6:644–7.
Alagna S, Cossu ML, Masala A, et al. Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery. Eat Weight Disord - Stud Anorexia, Bulim Obes. 2013;8(2):95–9.
Camastra S, Manco M, Frascerra S, et al. Daylong pituitary hormones in morbid obesity: effects of bariatric surgery. Int J Obes (Lond). 2009;33(1):166–72.
Weetman AP. Fortnightly review: Hypothyroidism: screening and subclinical disease. Br Med J. 1997;314:1175–8.
Harris M, Aschkenasi C, Elias C, et al. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocotrisignaling. J Clin Invest. 2001;107:111–20.
Nguyen KT, Korner J. The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr Diab Rep. 2014;14, no. 5:481.
Emami A, Nazem R, Hedayati M. Is association between thyroid hormones and gut peptides, ghrelin and obestatin, able to suggest new regulatory relation between the HPT axis and gut. Regul Pept. 2014;189C:17–21.
Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15, no. 7:1024–9.
Conflict of Interest
Dr. Yasmin Abu-Ghanem, Dr. Roy Inbar, Dr. Vitaly Tyomkin, Dr. Ilan Kent, Dr. Liron Berkovich, Dr. Ronen Ghinea, and Dr. Shmuel Avital declare that they have no conflict of interest.
Statement of Human and Animal Rights
This study has been approved by the appropriate institutional research committee and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Statement of Informed Consent
For this type of study (retrospective in nature), formal consent is not required. (An exemption from informed consent for this study was given by the institutional research committee as the data were retrospectively retrieved from an existing prospectively and routinely collected database.)
Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yasmin Abu-Ghanem and Roy Inbar contributed equally to this work.
Rights and permissions
About this article
Cite this article
Abu-Ghanem, Y., Inbar, R., Tyomkin, V. et al. Effect of Sleeve Gastrectomy on Thyroid Hormone Levels. OBES SURG 25, 452–456 (2015). https://doi.org/10.1007/s11695-014-1415-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-014-1415-7